Basic information Safety Supplier Related

tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate

Basic information Safety Supplier Related

tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate Basic information

Product Name:
tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate
Synonyms:
  • tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate
  • 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate
  • 2-Boc-6-hydroxy-2-aza-spi...
  • 2-Boc-6-hydroxy-2-aza-spiro[3.3]heptane
  • 6-Hydroxy-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester
  • 2-Azaspiro[3.3]heptane-2-carboxylic acid, 6-hydroxy-, 1,1-diMethylethyl ester
  • 6-Hydroxy-2-azaspiro[3.3]heptane, N-BOC protected
  • tert-Butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate, 2-(tert-Butoxycarbonyl)-6-hydroxy-2-azaspiro[3.3]heptane
CAS:
1147557-97-8
MF:
C11H19NO3
MW:
213.27
Mol File:
1147557-97-8.mol
More
Less

tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate Chemical Properties

Melting point:
127-129℃
Boiling point:
316.6±42.0 °C(Predicted)
Density 
1.17
storage temp. 
2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
14.84±0.20(Predicted)
form 
Solid
color 
White to Off-White
InChI
InChI=1S/C11H19NO3/c1-10(2,3)15-9(14)12-6-11(7-12)4-8(13)5-11/h8,13H,4-7H2,1-3H3
InChIKey
UMXXHZDEAZUQKZ-UHFFFAOYSA-N
SMILES
C1C2(CC(O)C2)CN1C(OC(C)(C)C)=O
More
Less

Safety Information

HS Code 
2934999090
More
Less

tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate Usage And Synthesis

Uses

tert-?Butyl 6-?Hydroxy-?2-?azaspiro[3.3]?heptane-?2-?carboxylate is a reactant used in the synthesis of pharmaceuticals such as CNS penetrant CXCR2 antagonists for the potential treatment of CNS demyelinating.

Synthesis

1181816-12-5

1147557-97-8

Step 8: Synthesis of tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate At 0 °C and under nitrogen protection, tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate (507 mg, 2.4 mmol) was dissolved in methanol (5.0 mL) and sodium borohydride (182 mg, 4.8 mmol) was added slowly. The reaction mixture was stirred at 0 °C for 30 min. After completion of the reaction, the solvent was concentrated in vacuum by rotary evaporator to give the crude product. Saturated sodium bicarbonate solution (30 mL) was added to the crude product and the aqueous phase was extracted with dichloromethane (4 x 30 mL). The organic phases were combined, dried with anhydrous sodium sulfate, filtered and concentrated in vacuum to afford tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate (5 mg, 100% yield) as a white solid.1H NMR (300 MHz, CDCl3): δ 4.18 (m, 1H), 3.88 (d, 4H), 2.53 (m, 2H), 2.08 (m. 2H), 1.42 (s, 9H).

References

[1] Patent: WO2013/13308, 2013, A1. Location in patent: Paragraph 00178-00180
[2] Journal of Medicinal Chemistry, 2017, vol. 60, # 13, p. 5663 - 5672
[3] Patent: CN106565706, 2017, A. Location in patent: Paragraph 0179; 0180; 0181
[4] Patent: EP3281942, 2018, A1. Location in patent: Paragraph 0105; 0106
[5] Patent: WO2018/133858, 2018, A1. Location in patent: Paragraph 00221

tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylateSupplier

Yutong Pharmaceutical Technology (Suzhou) Co., Ltd. Gold
Tel
0512-15851462628 15851462628
Email
2680463261@qq.com
BTC Pharmaceutical CO. Ltd Gold
Tel
15716293042 18862996710
Email
15050603958@163.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Nanjing Habo Medical Technology Co., Ltd.
Tel
025-85760892 13376080562
Email
sales@habotech.com
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com